Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Facebook
TwitterSales of CBD products in the United States stood at **** billion U.S. dollars in 2022. By 2026, this market is expected to grow to **** billion dollars in value.
Facebook
Twitterhttps://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
Europe CBD Product market size is USD 2344.56 million in 2024 and will expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.
Facebook
Twitterhttps://www.technavio.com/content/privacy-noticehttps://www.technavio.com/content/privacy-notice
Cannabidiol (CBD) Oil Market Size 2025-2029
The cannabidiol (cbd) oil market size is forecast to increase by USD 8.23 billion at a CAGR of 29.4% between 2024 and 2029.
The CBD oil market is experiencing significant growth, driven by increasing consumption among the millennial population in developed countries and the expanding legalization of cannabis-based products. This demographic trend, coupled with regulatory changes, presents a substantial opportunity for market expansion. However, the market is not without challenges. Adverse effects from overconsumption of CBD oil products, including potential liver damage and interactions with certain medications, pose a risk to consumers and may negatively impact market perception. Companies seeking to capitalize on this market must prioritize product safety and transparency, as well as invest in research and development to address these concerns and differentiate themselves from competitors. Additionally, navigating the complex regulatory landscape and maintaining compliance with varying laws and regulations will be crucial for market success. Overall, the CBD oil market offers significant potential for growth, but companies must address these challenges to effectively capitalize on the opportunities presented.
What will be the Size of the Cannabidiol (CBD) Oil Market during the forecast period?
Request Free SampleThe global CBD business is experiencing significant growth as this non-psychoactive compound derived from cannabis gains popularity for its various uses in treatments and consumer goods. Key market drivers include the legalization of CBD in several regions and the increasing acceptance of cannabidiol acids in medications, personal care items, and health and beauty products. CBD-based products come in various forms, including oils, capsules, transdermal patches, and vaping devices. Producers are continually refining manufacturing processes and testing methodologies to meet consumer demands for high-quality, safe products. Government measures and regulatory processes play a crucial role in shaping the market dynamics. For instance, stricter regulations on vaping devices have led to a shift towards other delivery methods like body lotions and tinctures. Consumer attitudes towards cannabis and related complications also influence the market trends. As more people turn to CBD for pain relief, anxiety reduction, and other health benefits, the demand for CBD-based treatments continues to rise. The variety of uses for CBD extends beyond human applications. Producers are exploring opportunities in pet care and pharmaceuticals, further expanding the market's reach. Processing techniques and cannabis strains with high CBD content are under constant development to cater to the evolving consumer preferences and regulatory requirements.
How is this Cannabidiol (CBD) Oil Industry segmented?
The cannabidiol (cbd) oil industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductMarijuana derived CBD oilHemp derived CBD oilApplicationPharmaceuticalsPersonal care and cosmeticsFood and beveragesWellnessGeographyNorth AmericaUSCanadaAPACChinaIndiaJapanSouth KoreaEuropeFranceGermanyItalyUKSouth AmericaMiddle East and Africa
By Product Insights
The marijuana derived cbd oil segment is estimated to witness significant growth during the forecast period.CBD oil derived from marijuana is gaining popularity among consumers due to its broader range of therapeutic components, including cannabinoids, terpenes, and other chemicals found in the cannabis plant. Known as full-spectrum CBD oil, this product is believed to have an entourage effect, where the synergistic interaction of these components enhances the overall therapeutic benefits of CBD. The potential medicinal advantages of marijuana-derived CBD oil, such as pain relief, anxiety reduction, and potential anti-inflammatory properties, are driving demand for this product. As research progresses and more information becomes available, consumer acceptance of marijuana-derived CBD oil as a natural remedy for various health conditions continues to grow. This trend is not limited to humans but extends to pets and health and beauty industries, with CBD-based products being used in medical therapies, cosmetics, and personal care items. The legalization of marijuana and CBD in several countries and regions is further fueling the global CBD business, leading to the development of new manufacturing processes and products, such as capsules, tinctures, transdermal patches, and inhalation devices. Governments and regulatory bodies are implementing measures to ensure health safety assurance and consumer-facing openness, while producers are focusing on Food Grade and Therapeutic Grade quality to cater to the evol
Facebook
Twitterhttps://www.technavio.com/content/privacy-noticehttps://www.technavio.com/content/privacy-notice
Cannabidiol (CBD) Market Size 2025-2029
The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.
The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.
What will be the Size of the Cannabidiol (CBD) Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.
Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.
The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.
How is this Cannabidiol (CBD) Industry segmented?
The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Source
Marijuana
Hemp
Distribution Channel
Offline
Online
End-user
Medical
Personal use
Wellness
Geography
North America
US
Canada
Mexico
Europe
France
Germany
UK
APAC
China
India
Japan
South Korea
Rest of World (ROW)
.
By Source Insights
The marijuana segment is estimated to witness significant growth during the forecast period.
CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product innovation.
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The CBD Oil Market is estimated to be valued at USD 0.8 billion in 2025 and is projected to reach USD 12.5 billion by 2035, registering a compound annual growth rate (CAGR) of 31.0% over the forecast period.
| Metric | Value |
|---|---|
| CBD Oil Market Estimated Value in (2025 E) | USD 0.8 billion |
| CBD Oil Market Forecast Value in (2035 F) | USD 12.5 billion |
| Forecast CAGR (2025 to 2035) | 31.0% |
Facebook
TwitterIt is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.
What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.
CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.
Facebook
Twitterhttps://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
Discover the booming CBD market! Our comprehensive analysis reveals key trends, growth drivers, and regional insights for CBD oil, capsules, topicals & more. Explore market size projections, competitive landscape & top players from 2019-2033.
Facebook
Twitterhttps://www.psmarketresearch.com/privacy-policyhttps://www.psmarketresearch.com/privacy-policy
The CBD oil market was valued at $5,230.9 million in 2024 and will reach $23,483.2 million by 2032, advancing at a CAGR of 20.8% during 2025-2032.
Facebook
Twitterhttps://www.marknteladvisors.com/privacy-policyhttps://www.marknteladvisors.com/privacy-policy
Global Cannabidiol Market size was valued at around USD 22.7 billion in 2023 and is projected to grow at a CAGR of around 19.21% during the forecast period 2024-30. increasing popularity of functional CBD products is one of the key trends shaping the growth of cbd market.
Facebook
Twitterhttps://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
Discover the booming CBD consumer products market! Explore a comprehensive analysis projecting $75 billion by 2033, driven by increasing consumer demand, legalization, and product innovation. Learn about key players, market segments, and regional trends in this rapidly expanding industry.
Facebook
Twitterhttps://www.verifiedmarketresearch.com/privacy-policy/https://www.verifiedmarketresearch.com/privacy-policy/
CBD Oil Market size was valued at USD 24.99 Billion in 2024 and is projected to reach USD 281.52 Billion by 2032, growing at a CAGR of 39% from 2026 to 2032.Rising Awareness of Health Benefits: One of the most significant drivers of the CBD oil market is the rising awareness of its myriad potential health benefits. Consumers are actively seeking natural alternatives for a range of ailments, and CBD, derived from the cannabis plant, is gaining traction due to its non psychoactive properties and therapeutic potential.Increasing Legalization of Cannabis Products: The increasing legalization of cannabis products across various regions is undeniably a monumental force behind the CBD oil market's boom. As more countries and states decriminalize or legalize cannabis for medicinal and recreational use, the regulatory landscape for CBD derived from hemp (which contains less than 0.3% THC) becomes clearer and more favorable.
Facebook
Twitterhttps://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the global CBD Product market size is USD 7815.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 16.20% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 3126.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 2344.56 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1797.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031.
Latin America market of more than 5% of the global revenue with a market size of USD 390.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 156.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.9% from 2024 to 2031.
The Hemp held the highest CBD Product market revenue share in 2024.
Market Dynamics of CBD Product Market
Key Drivers of CBD Product Market
Growing Scientific Research to Increase the Demand Globally
Promising effects of CBD are still being found in science for a number of ailments, including anxiety, pain, inflammation, and sleep difficulties. The amount of evidence that is accumulating is increasing customer interest and propelling the CBD market's notable growth. Research suggests that CBD can reduce symptoms and enhance quality of life, which is why people looking for natural substitutes for traditional treatments are adopting it at a higher rate. Demand for CBD products is rising as more people become aware of its potential therapeutic benefits, which is indicative of a move toward more holistic wellness strategies. This pattern emphasizes how crucial it is to continue researching CBD in order to understand its workings and maximize its effectiveness for a range of medical issues.
Legalization and Regulatory Changes to Propel Market Growth
An important turning point was reached when the 2018 Farm Bill was passed in the US, legalizing CBD derived from hemp and creating a plethora of new market potential. A framework for the manufacture, marketing, and distribution of CBD products was established by this regulatory milestone, which promoted greater consumer confidence and accessibility. The worldwide CBD market was further supported by parallel regulatory changes in other countries, which also created an atmosphere that was more conducive to innovation, research, and commercialization. Because of this, the CBD market is expanding and offers a wide range of products to suit different needs and tastes. These legislative reforms have not only accelerated economic growth but also made CBD's potential health advantages more accessible to consumers, highlighting the importance of changing regulatory environments in determining the direction of the CBD market.
Restraint Factors of CBD Product Market
Stringent Regulations and Compliance Challenges to Limit the Sales
Tight laws and differing standards of compliance present major obstacles for CBD producers and sellers, requiring careful maneuvering to guarantee compliance with various legal systems in various nations and jurisdictions. The disarray of rules not only makes operations more difficult, but it also raises the expense of compliance because companies have to spend a lot of money on legal counsel and in-depth study to stay current with changing standards. Furthermore, inconsistent restrictions can impede market expansion and breed uncertainty, which makes it harder for companies to grow and innovate. Despite these difficulties, maintaining long-term viability and fostering consumer trust in the quickly developing CBD market require aggressive interaction with regulatory agencies and investments in strong compliance standards.
Impact of Covid-19 on the CBD Product Market
The COVID-19 pandemic had a variety of effects on the CBD product market. Sales first declined as a result of supply chain disruptions and store closings. However, as the epidemic spread, there was a noticeable spike in demand for CBD products due to a rise in people turning to natural solutions for their stress, anxiety, and sleep difficulties. The number ...
Facebook
Twitterhttps://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The global CBD hemp oil market is experiencing robust growth, driven by increasing consumer awareness of its potential health benefits and the expanding legalization of cannabis-derived products. While precise market sizing data for 2025 is unavailable, leveraging industry reports and the stated study period (2019-2033), a reasonable estimate places the 2025 market value at approximately $2.5 billion USD. This is based on an assumed, steady growth rate considering the market's maturity and regulatory hurdles in certain regions. Key growth drivers include the increasing prevalence of anxiety and chronic pain, the rising popularity of holistic wellness approaches, and the growing acceptance of CBD as a natural remedy. Market trends show a shift towards high-quality, organically sourced CBD products, along with innovative delivery methods like topical creams and edibles. However, regulatory uncertainty in some countries and inconsistent product quality pose significant restraints to market expansion. The market is segmented by product type (oils, capsules, topicals, etc.), application (anxiety, pain relief, sleep disorders, etc.), and distribution channel (online, retail stores, pharmacies). Leading companies like Cannavest, Pharmahemp, and Endoca are actively innovating and expanding their product lines to meet the evolving consumer demand. Looking ahead to 2033, the market is projected to maintain substantial growth. Continued scientific research validating the therapeutic benefits of CBD, combined with strategic marketing and product diversification by market players, will fuel expansion. The growth, however, will be influenced by ongoing regulatory changes. Regions with progressive cannabis policies, such as North America and certain parts of Europe, are expected to dominate the market share. The focus will be on transparency and quality control as consumers become increasingly discerning about the source and purity of their CBD products. Companies are likely to invest heavily in research and development to improve product efficacy and explore new applications for CBD hemp oil.
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
CBD Pet Products Market Report is Segmented by Type (Food-Grade and Therapeutic-Grade), Animal Type (Dog, Cat, and Other Pets), Distribution Channel (Online Retail Channels, Retail Pharmacies, Veterinary Clinics, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, South America, and Africa). The Report Offers Market Size and Forecasts in Terms of Value (USD) for all the Above Segments.
Facebook
TwitterCBD vitamins and dietary supplements (VDS) had the greatest market penetration among cannabidiol (CBD) products in the world, with CBD product penetration of the overall vitamin and dietary supplement market at **** percent in 2019. By 2027, CBD is expected to account for over ** percent of this market segment.
Facebook
Twitterhttps://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
CBD product manufacturers are fresh from a whirlwind five-year stretch that's seen every primary market driver—input prices, consumer demand and regulation—rapidly evolve. Early pandemic anxiety and shifting wellness priorities sparked surging first-time use, feeding a wave of new manufacturers and fueling unprecedented growth. But as the market matured, rising input costs, abrupt regulatory changes and tightening retailer standards ushered in a tougher, more fragmented playbook. Gone are the days when novelty and mass SKU expansion alone could move the needle. Instead, we're seeing an industry marked by heightened operational discipline, defensive pivots into compliant topicals and ingestibles and a sharp shakeout of less resilient brands. Employment is now consolidated among larger, nimble producers with deep channel partnerships, efficient co-manufacturing relationships and the ability to readjust product mixes quickly. Revenue has been expanding at a CAGR of 8.0% over the past five years, bolstered mainly by early-period, double-digit growth. In 2025, revenue fell 2.5%, totalling $1.3 billion. Leading retailers have installed steep onboarding barriers, demanding bulletproof documentation, QA and supply-chain transparency. Many smaller and early-stage manufacturers—unable to invest in new requirements—are either losing placements or exiting altogether. This gating effect has accelerated the concentration of sales among the best-prepared producers, particularly those specializing in pharmacy- or beauty-channel SKUs. Meanwhile, input price volatility remains a thorn in the industry's side, repeatedly forcing producers to recalibrate pricing, delay launches and reduce promotional activity. These dynamics fuel competitive churn: top operators are scaling up with high-efficiency runs and broader channel access, while less adaptable brands face permanent contraction. The stage is set for a strategic transformation led by pharmaceutical-grade integration, AI-driven personalization and consolidation through 2030. Forward-thinking manufacturers will drive industry evolution by investing in clinical-grade manufacturing, robust data systems and flexible, personalized product lines. Market growth should be steadier, if less meteoric, as an expected set of regulatory reforms around over-the-counter access and supply-chain traceability further favor scalable, compliant leaders. The emergence of a handful of platform-scale producers—armed with the infrastructure to secure premium contracts, rapid manufacturing runs and national retail access—isn't just likely, it's fast becoming a prerequisite for industry dominance. Those able to blend pharmaceutical credibility, operational agility and regulatory foresight are expected to command the lion's share of revenue moving forward. Revenue is forecast to expand at a CAGR of 6.5% over the next five years, reaching $1.7 billion in 2030.
Facebook
Twitterhttps://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
Middle East and Africa CBD Product market size is USD 156.30 million in 2024 and will expand at a compound annual growth rate (CAGR) of 15.9% from 2024 to 2031.
Facebook
Twitterhttps://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
The global cannabidiol oil (CBD oil) market is experiencing robust growth, projected to reach a market size of $5,046 million in 2025, exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 27.6% from 2019 to 2033. This significant expansion is driven by several key factors. Increasing consumer awareness of CBD's potential therapeutic benefits for anxiety, pain relief, and sleep disorders is fueling demand across various applications. The expanding legalization and regulatory frameworks in numerous countries are further facilitating market penetration. The versatility of CBD oil, enabling its incorporation into pharmaceuticals, food products, cosmetics, and other consumer goods, contributes to its broad appeal and market diversification. Strong consumer interest in natural and holistic health solutions further enhances market prospects. The market is segmented by derivation (hemp-derived and marijuana-derived) and application (pharmaceuticals, food, cosmetics, and others), providing opportunities for specialized product development and targeted marketing strategies. Competition among established players and emerging brands is shaping pricing and innovation within the sector. Despite the rapid growth, challenges remain, including inconsistent regulatory landscapes across different jurisdictions and concerns about product quality and standardization. The market's future trajectory hinges on continued research and development supporting the efficacy and safety of CBD products, coupled with clear regulatory guidelines ensuring consumer protection. Growth will be influenced by consumer adoption patterns, evolving health trends, and the introduction of innovative CBD-infused products. Further geographic expansion into emerging markets, where awareness of CBD benefits is still developing, holds significant potential for market growth. The success of individual companies within this dynamic market will depend on their ability to adapt to changing regulations, invest in research and development, and establish strong brand recognition and customer loyalty. The significant CAGR suggests a substantial increase in market value over the forecast period, reflecting the continued dynamism and growth potential of the global CBD oil market.
Facebook
TwitterIn 2023, the sales value of cannabidiol (CBD) in Japan exceeded ** million U.S. dollars. The CBD market was projected to grow continuously in the following years, reaching almost ** million dollars in 2027. Cannabis is a controlled drug in Japan, for which recreational and medicinal uses are prohibited. While CBD products without the psychoactive component tetrahydrocannabinol (THC) can be legally distributed, the ban on cannabis cultivation makes imports the main procurement channel of the derivative.
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).